-
Je něco špatně v tomto záznamu ?
The interplay between bicarbonate kinetics and gastrointestinal upset on ergogenic potential after sodium bicarbonate intake: a randomized double-blind placebo-controlled trial
K. Durkalec-Michalski, PM. Nowaczyk, J. Kamińska, B. Saunders, I. Łoniewski, D. Czubaszek, M. Steffl, T. Podgórski
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu randomizované kontrolované studie, časopisecké články, práce podpořená grantem
NLK
Directory of Open Access Journals
od 2011
Free Medical Journals
od 2011
Nature Open Access
od 2011-12-01
PubMed Central
od 2011
Europe PubMed Central
od 2011
ProQuest Central
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2011
Springer Nature OA/Free Journals
od 2011-12-01
- MeSH
- dvojitá slepá metoda MeSH
- gastrointestinální nemoci * chemicky indukované MeSH
- hydrogenuhličitan sodný škodlivé účinky MeSH
- hydrogenuhličitany MeSH
- klinické křížové studie MeSH
- lidé MeSH
- polyestery MeSH
- sportovní výkon * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
This double-blind placebo-controlled cross-over study utilized comprehensive monitoring of blood bicarbonate (HCO3 ̄) kinetics and evaluation of gastrointestinal (GI) upset to determine their impact on an ergogenic potential of sodium bicarbonate (SB) co-ingested with carbohydrate (CHO). Nineteen CrossFit athletes performed 6 bouts of 15 s Wingate Anaerobic Test (WAnT) 90 min post-ingestion of 0.4 g·kg-1 body mass (BM) of SB (SB + CHO treatment) or PLA (PLA + CHO treatment) with 15 g CHO. Blood HCO3 ̄ concentration was evaluated at baseline, 30-, 60-, 75- and 90 min post-ingestion, in between WAnT bouts, and 3 and 45 min post-exercise, while GI upset at 120 min after protocol started. Control (no supplementation; CTRL) procedures were also performed. An effective elevation of extra-cellular buffering capacity was observed 60-90 min post-ingestion of SB + CHO. At mean peak blood HCO3 ̄, or at start of exercise an increase > 6 mmol·L-1 in HCO3 ̄ was noted in 84% and 52.6% participants, respectively. SB + CHO did not prevent performance decrements in WAnT bouts. There were no significant relationships between changes in blood HCO3 ̄ and WAnTs' performance. Total GI was significantly higher in SB + CHO compared to CTRL, and stomach problems in SB + CHO compared to CTRL and PLA + CHO. There were inverse associations between peak- (p = 0.031; r = - 0.495), average- (p = 0.002; r = - 0.674) and minimum power (p = 0.008; r = - 0.585) and total GI upset, as well as average power and severe GI distress (p = 0.042; r = - 0.471) at SB + CHO. The implemented dose of SB + CHO was effective in improving buffering capacity, but did not prevent decrements in WAnTs' performance. GI side effects were crucial in affecting the ergogenic potential of SB and thus must be insightfully monitored in future studies.
Department of Biochemical Sciences Pomeranian Medical University in Szczecin Szczecin Poland
Department of Physiology and Biochemistry Poznan University of Physical Education Poznan Poland
Department of Sports Dietetics Poznan University of Physical Education 61 871 Poznan Poland
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23011520
- 003
- CZ-PrNML
- 005
- 20230801133116.0
- 007
- ta
- 008
- 230718s2023 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41598-023-34343-0 $2 doi
- 035 __
- $a (PubMed)37127791
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Durkalec-Michalski, Krzysztof $u Department of Sports Dietetics, Poznan University of Physical Education, 61-871, Poznan, Poland. durkalec-michalski@awf.poznan.pl $u Sport Sciences-Biomedical Department, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic. durkalec-michalski@awf.poznan.pl
- 245 14
- $a The interplay between bicarbonate kinetics and gastrointestinal upset on ergogenic potential after sodium bicarbonate intake: a randomized double-blind placebo-controlled trial / $c K. Durkalec-Michalski, PM. Nowaczyk, J. Kamińska, B. Saunders, I. Łoniewski, D. Czubaszek, M. Steffl, T. Podgórski
- 520 9_
- $a This double-blind placebo-controlled cross-over study utilized comprehensive monitoring of blood bicarbonate (HCO3 ̄) kinetics and evaluation of gastrointestinal (GI) upset to determine their impact on an ergogenic potential of sodium bicarbonate (SB) co-ingested with carbohydrate (CHO). Nineteen CrossFit athletes performed 6 bouts of 15 s Wingate Anaerobic Test (WAnT) 90 min post-ingestion of 0.4 g·kg-1 body mass (BM) of SB (SB + CHO treatment) or PLA (PLA + CHO treatment) with 15 g CHO. Blood HCO3 ̄ concentration was evaluated at baseline, 30-, 60-, 75- and 90 min post-ingestion, in between WAnT bouts, and 3 and 45 min post-exercise, while GI upset at 120 min after protocol started. Control (no supplementation; CTRL) procedures were also performed. An effective elevation of extra-cellular buffering capacity was observed 60-90 min post-ingestion of SB + CHO. At mean peak blood HCO3 ̄, or at start of exercise an increase > 6 mmol·L-1 in HCO3 ̄ was noted in 84% and 52.6% participants, respectively. SB + CHO did not prevent performance decrements in WAnT bouts. There were no significant relationships between changes in blood HCO3 ̄ and WAnTs' performance. Total GI was significantly higher in SB + CHO compared to CTRL, and stomach problems in SB + CHO compared to CTRL and PLA + CHO. There were inverse associations between peak- (p = 0.031; r = - 0.495), average- (p = 0.002; r = - 0.674) and minimum power (p = 0.008; r = - 0.585) and total GI upset, as well as average power and severe GI distress (p = 0.042; r = - 0.471) at SB + CHO. The implemented dose of SB + CHO was effective in improving buffering capacity, but did not prevent decrements in WAnTs' performance. GI side effects were crucial in affecting the ergogenic potential of SB and thus must be insightfully monitored in future studies.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hydrogenuhličitan sodný $x škodlivé účinky $7 D017693
- 650 _2
- $a hydrogenuhličitany $7 D001639
- 650 _2
- $a klinické křížové studie $7 D018592
- 650 12
- $a gastrointestinální nemoci $x chemicky indukované $7 D005767
- 650 _2
- $a polyestery $7 D011091
- 650 _2
- $a dvojitá slepá metoda $7 D004311
- 650 12
- $a sportovní výkon $7 D054874
- 655 _2
- $a randomizované kontrolované studie $7 D016449
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Nowaczyk, Paulina M $u Department of Sports Dietetics, Poznan University of Physical Education, 61-871, Poznan, Poland
- 700 1_
- $a Kamińska, Joanna $u Department of Physiology and Biochemistry, Poznan University of Physical Education, Poznan, Poland
- 700 1_
- $a Saunders, Bryan $u Applied Physiology and Nutrition Research Group, School of Physical Education and Sport, Rheumatology Division, Faculdade de Medicina FMUSP, University of São Paulo, São Paulo, Brazil $u Institute of Orthopedics and Traumatology, Faculty of Medicine FMUSP, University of São Paulo, São Paulo, Brazil
- 700 1_
- $a Łoniewski, Igor $u Department of Biochemical Sciences, Pomeranian Medical University in Szczecin, Szczecin, Poland
- 700 1_
- $a Czubaszek, Dominika $u Department of Sports Dietetics, Poznan University of Physical Education, 61-871, Poznan, Poland
- 700 1_
- $a Steffl, Michal $u Sport Sciences-Biomedical Department, Faculty of Physical Education and Sport, Charles University, Prague, Czech Republic
- 700 1_
- $a Podgórski, Tomasz $u Department of Physiology and Biochemistry, Poznan University of Physical Education, Poznan, Poland
- 773 0_
- $w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 13, č. 1 (2023), s. 7081
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37127791 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230718 $b ABA008
- 991 __
- $a 20230801133112 $b ABA008
- 999 __
- $a ok $b bmc $g 1963751 $s 1197785
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 13 $c 1 $d 7081 $e 20230501 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
- LZP __
- $a Pubmed-20230718